Taizhou Volsen Chemical Co., Ltd.
ホーム > ブログ> Pralsetinib

Pralsetinib

January 15, 2024
Pralsetinib cas number 2097132-94-8 ,also known as GAVRETO, is a RET receptor tyrosine kinase inhibitor for the treatment of metastatic RET-driven non-small cell lung cancer. It is used to treat certain cancers caused by abnormal RET genes.iT is a targeted therapy that is taken by mouth once daily. 
お問い合わせ

Author:

Ms. Amy Cheng

Eメール:

info@volsenchem.com

Phone/WhatsApp:

008613566652212

人気商品
Blog News
What is the Tapinarof?

January 02, 2024

Tezacaftor and Ivacaftor

December 29, 2023

You may also like
Related Categories

この仕入先にメール

タイトル:
イーメール:
メッセージ:

Your message must be betwwen 20-8000 characters

お問い合わせ

Author:

Ms. Amy Cheng

Eメール:

info@volsenchem.com

Phone/WhatsApp:

008613566652212

人気商品
Blog News
What is the Tapinarof?

January 02, 2024

Tezacaftor and Ivacaftor

December 29, 2023

ホーム

Product

Phone

私たちに関しては

お問い合わせ

We will contact you immediately

Fill in more information so that we can get in touch with you faster

Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.

送信